ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

ABI

59.68

0%↓

CDI

441

+0.36%↑

128

+1.15%↑

40.19

-0.4%↓

HEIO

61.15

+0.49%↑

Home・Aandelen Lijst・Bonduelle SCA

Bonduelle SCA

Gesloten

8.47 3.04

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.03

Max

8.47

Belangrijke statistieken
By Trading Economics
Inkomsten	-6.4M
Verkoop	27M 1.1B
K/W Sectorgemiddelde	12.254 27.787
Dividendrendement	3.05
Winstmarge	-0.594
Werknemers	7,625
EBITDA	1.1B 51M

Aanbevelingen
By TipRanks
Aanbevelingen	Sell
12 Maanden Prognose	-2.32% downside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	3.05% 3.82%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-63M 263M
Vorige openingsprijs	5.43
Vorige sluitingsprijs	8.47

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

7.53 / 8.3 Steun & Weerstand

Bonduelle SCA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 mrt 2026, 23:31 UTC

Populaire aandelen

Stocks to Watch: Nike, RH, NCino

31 mrt 2026, 22:35 UTC

Winsten

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 apr 2026, 00:00 UTC

Acquisities, Fusies, Overnames

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mrt 2026, 23:50 UTC

Acquisities, Fusies, Overnames

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mrt 2026, 23:43 UTC

Marktinformatie

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mrt 2026, 23:33 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mrt 2026, 23:21 UTC

Winsten

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mrt 2026, 23:14 UTC

Marktinformatie

Winsten

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mrt 2026, 23:12 UTC

Marktinformatie

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Loss Widens >000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mrt 2026, 22:36 UTC

Winsten

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mrt 2026, 21:46 UTC

Acquisities, Fusies, Overnames

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mrt 2026, 21:36 UTC

Marktinformatie

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mrt 2026, 21:35 UTC

Winsten

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mrt 2026, 21:35 UTC

Winsten

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mrt 2026, 21:35 UTC

Winsten

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mrt 2026, 21:33 UTC

Winsten

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mrt 2026, 21:32 UTC

Winsten

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mrt 2026, 21:28 UTC

Winsten

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mrt 2026, 21:26 UTC

Winsten

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mrt 2026, 21:25 UTC

Winsten

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mrt 2026, 21:24 UTC

Marktinformatie

Winsten

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mrt 2026, 21:22 UTC

Winsten

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mrt 2026, 21:22 UTC

Winsten

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mrt 2026, 21:21 UTC

Winsten

Nike's Digital Channel Still Too Promotional, CFO Says

31 mrt 2026, 21:20 UTC

Winsten

Nike CEO: Converse Remains Important to Portfolio

Peer Vergelijking

Prijswijziging

Bonduelle SCA Prognose

Koersdoel

By TipRanks

-2.32% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 8 EUR -2.32%

Hoogste 8 EUR

Laagste 8 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bonduelle SCA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Bonduelle SCA - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

7.53 / 8.3Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bullish.

Financieel

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Bonduelle SCA

Bonduelle SCA produces, processes, and sells vegetables in Europe and internationally. The company offers canned, frozen, ready-to-use vegetables; and pulses, fruits, and aromatics. It provides its products under the Bonduelle, Cassegrain, Globus, and Ready Pac Foods brands. The company was founded in 1853 and is headquartered in Renescure, France.